Sunday August 20th 2017

Archive for February, 2016

Individual Face‐to‐Face Cognitive Behavioural Therapy in Multiple Sclerosis: A Qualitative Study

Individual Face‐to‐Face Cognitive Behavioural Therapy in Multiple Sclerosis: A Qualitative Study

ConclusionIt is important to inform the participants of what CBT entails so that they are mentally prepared for the demanding process and can make the necessary adjustments in their daily life. Knowledge of MS among the therapists as well as collaboration with the [Read More]

Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training

Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training

ConclusionIn conclusion, BDNF concentration of persons with RRMS was lower compared to HCs and increased after 24 weeks of exercise in persons with MS, compared to the non‐exercise MS control group. (Source: European Journal of Neurology) [Read More]

An Open-Label Study to Assess Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect (PBA) in Dementia, Stroke…

An Open-Label Study to Assess Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect (PBA) in Dementia, Stroke…

Introduction: Pseudobulbar affect (PBA) is a neurologic condition characterized by laughing and crying episodes that are uncontrollable, disruptive, and generally incongruent with social context and prevailing mood. PBA can occur secondary to a variety of unrelated [Read More]

 Page 1 of 116  1  2  3  4  5 » ...  Last »